World's Best Scientists 2026 revealed!
Jonas S. Erjefält

Jonas S. Erjefält

D-Index & Metrics

Immunology

D-Index
65
Citations
12145
World Ranking
2877
National Ranking
62

Overview

Jonas S. Erjefält is affiliated with Lund University in Sweden, focusing primarily on medicine and immunology and microbiology. Their research concentrates on pulmonary and respiratory medicine, physiology, immunology, immunology and allergy, and surgery.

The scientist has contributed significantly to topics including asthma and respiratory diseases, IL-33, ST2, and ILC pathways, respiratory and cough-related research, eosinophilic esophagitis, interstitial lung diseases and idiopathic pulmonary fibrosis, allergic rhinitis and sensitization, and chronic obstructive pulmonary disease (COPD) research.

Frequent co-authors of Jonas S. Erjefält include:

  • Premkumar Siddhuraj
  • Caroline Sandén
  • Leif Bjermer
  • Celeste Porsbjerg
  • Morten Hvidtfeldt

Key publication venues where their work appears most often are:

  • Frontiers in Immunology
  • European Respiratory Journal
  • Journal of Allergy and Clinical Immunology
  • Cells
  • ERJ Open Research

Representative recent papers include:

  • The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM), 2021, European Respiratory Journal
  • Small-molecule-mediated OGG1 inhibition attenuates pulmonary inflammation and lung fibrosis in a murine lung fibrosis model, 2023, Nature Communications
  • Oxidised IL-33 drives COPD epithelial pathogenesis via ST2-independent RAGE/EGFR signalling complex, 2023, European Respiratory Journal
  • Eosinophils, basophils and type 2 immune microenvironments in COPD-affected lung tissue, 2020, European Respiratory Journal
  • Microbial Regulation of Enteric Eosinophils and Its Impact on Tissue Remodeling and Th2 Immunity, 2020, Frontiers in Immunology

Jonas S. Erjefält has also contributed to book publications, including one published by Frontiers Media titled Pulmonary Fibrosis: One Manifestation, Various Diseases (2022).

Best Publications

  • MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function.

    Roland Kolbeck;Alexander Kozhich;Masamichi Koike;Li Peng

  • IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs

    Suzanne M. Bal;Jochem H Bernink;Maho Nagasawa;Jelle Groot

  • Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs

    Jonathan S Silver;Jennifer Kearley;Alan M Copenhaver;Caroline Sanden

  • Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity.

    Sterghios Athanasios Moschos;Simon Wyn Jones;Mark Michael Perry;Andrew Evan Williams

  • Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice

    Magnus Korsgren;Jonas Erjefält;Olle Korsgren;Frank Sundler

  • Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection.

    Jennifer Kearley;Jonathan S. Silver;Caroline Sanden;Zheng Liu

  • In vivo restitution of airway epithelium.

    Jonas S. Erjefält;Ingrid Erjefält;Frank Sundler;Carl G. A. Persson

  • IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways.

    Jennifer Kearley;Jonas S. Erjefalt;Cecilia Andersson;Ebony Benjamin

  • Effectiveness of bronchial thermoplasty in patients with severe refractory asthma: Clinical and histopathologic correlations

    Marina Pretolani;Anders Bergqvist;Gabriel Thabut;Marie Christine Dombret

  • MicroRNA Expression Profiling in Mild Asthmatic Human Airways and Effect of Corticosteroid Therapy

    Andrew E. Williams;Hanna Larner-Svensson;Mark M. Perry;Gaynor A. Campbell

  • Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways.

    Jonas S. Erjefält;Lennart Greiff;Morgan Andersson;Erik Matsson

  • New aspects of degranulation and fates of airway mucosal eosinophils.

    Jonas S. Erjefält;Carl G. A. Persson

  • Novel site-specific mast cell subpopulations in the human lung

    Cecilia K Andersson;Michiko Mori;Leif Bjermer;Claes-Göran Löfdahl

  • Indigenous enteric eosinophils control DCs to initiate a primary Th2 immune response in vivo.

    Derek K Chu;Rodrigo Jimenez-Saiz;Christopher P Verschoor;Tina D Walker

  • Alterations in lung mast cell populations in patients with chronic obstructive pulmonary disease

    Cecilia K. Andersson;Michiko Mori;Leif Bjermer;Claes-Göran Löfdahl

  • Up-regulation of Toll-like receptors 2, 3 and 4 in allergic rhinitis

    Mattias Fransson;Mikael Adner;Jonas Erjefält;Lennart Jansson

  • IL-17A is Elevated in End-stage COPD and Contributes to Cigarette Smoke-induced Lymphoid Neogenesis.

    Abraham B. Roos;Caroline Sandén;Michiko Mori;Leif Bjermer

  • Cytolysis and piecemeal degranulation as distinct modes of activation of airway mucosal eosinophils

    Jonas Erjefält;M Andersson;Lennart Greiff;M Korsgren

  • Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven disease

    Jonas Erjefält;Lennart Greiff;M Andersson;E Ädelroth

  • Degranulation status of airway tissue eosinophils in mouse models of allergic airway inflammation.

    Monika Malm-Erjefält;Carl G. A. Persson;Jonas S. Erjefält

Frequent Co-Authors

Leif Bjermer
Leif Bjermer Lund University
Carl G. A. Persson
Carl G. A. Persson Lund University
Frank Sundler
Frank Sundler Lund University
Matthias Mörgelin
Matthias Mörgelin Lund University
Roland Kolbeck
Roland Kolbeck AstraZeneca (United Kingdom)
Martin R. Stämpfli
Martin R. Stämpfli McMaster University
Vibeke Backer
Vibeke Backer Rigshospitalet
Manel Jordana
Manel Jordana McMaster University
Karsten Kristiansen
Karsten Kristiansen University of Copenhagen
Christer Svensson
Christer Svensson Linköping University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many professionals choose to enhance their clinical skills by pursuing certifications like the fnp to acute care certification, which allows family nurse practitioners to specialize in high-acuity settings.

Accelerated programs are particularly popular for students aiming to fast-track their nursing careers. The accelerated fnp pathways offer a streamlined curriculum designed for individuals who already hold a bachelor's degree and want to become family nurse practitioners efficiently.

For those without a nursing background, 12-month accelerated nursing programs online for non nurses provide an excellent option to enter the field quickly. These programs are designed to equip learners with foundational nursing knowledge at an accelerated pace.

If accessibility is a priority, many institutions offer accelerated nursing programs that have more flexible admission criteria, helping more students begin their nursing education without extensive prerequisites.

By combining immunology studies with nursing and advanced practice degrees, learners can position themselves for vital roles in healthcare, research, and patient care.

Best Scientists Citing Jonas S. Erjefält

Trending Scientists

Recently Published Articles